Dexmedetomidine infusion for the management of opioid-induced hyperalgesia

Pain Medicine

Volumn 11, Issue 12, 2010, Pages 1819-1826

  Belgrade, Miles ^a   Hall, Sara ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Alpha 2 Adrenergic Agonists; Dexmedetomidine; Opioid Tolerance; Opioid Withdrawal; Opioid Induced Hyperalgesia

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE;

ADOLESCENT; ADULT; ANTINOCICEPTION; ARTICLE; BRADYCARDIA; CHILD; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG INFUSION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERALGESIA; HYPOTENSION; MALE; NOCICEPTION;

EID: 78650092234     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00973.x     Document Type: Article

References (32)

1. Chu LF, Angst MD, Clark D. Opioid-induced hyperalgesia in humans. Clin J Pain 2008;24:479-96.
2. Stanos SP, Fishbain DA, Fishman SM. Pain management with opioid analgesics: Balancing risk & benefit. Am J Phys Med Rehabil 2009;88(suppl 2):S69-99.
3. Angst MS, Clark JD. Opioid-induced hyperalgesia. Anesthesiology 2006;104:570-87.
4. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain 2006;7:43-8.
5. Bannister K, Dickenson AH. Opioid hyperalgesia. Curr Opin Support Palliat Care 2010;4:1-5.
6. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009;10(5):829-39.
7. Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000;93:409-17.
8. Cortinez LI, Brandes V, Munoz HR, Guerrero ME, Mur M. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001;87:866-9.
9. Dunbar SA, Pulai IJ. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. J Pharmacol Exp Ther 1998;284:678-86.
10. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 2002;100:213-7.
11. Mao J, Sung B, Ji RR, Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: Implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002;22:8312-23.
12. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 1995;62:259-74.
13. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid dependent patient. Anesthesiology 2004;101:212-27.
14. Carroll IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 2004;29(6):576-91.
15. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: A case-controlled retrospective review. Pain 1995;61:195-201.
16. Jorden VS, Tung A. Dexmedetomidine: Clinical update. Semin Anesth Perioper Med Pain 2002;21:265-74.
17. Gerlach AT, Dasta JF. Dexmedetomidine: An updated review. Ann Pharmacother 2007;41:245-54.
18. Cortinez LI, Hsu YW, Sum-Ping ST, et al. Dexmedetomidine pharmacodynamics: Part II. Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004;101:1077-83.
19. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 2004;98:153-8.
20. Aho MS, Erkola OA, Scheinin H, Lehtinen AM, Korttila KT. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 1991;73:112-8.
21. Golembiewski J. Dexmedetomidine--Does it have a role in the perioperative setting? J Perianesth Nurs 2005;20:289-91.
22. Finkel JC, Elrefai A. The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg 2004;98:1658-9.
23. Finkel JC, Johnson YJ, Quezado MN. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005;33:2110-2.
24. Tobias JD. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag 2006;2:201-5.
25. Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003;96:1054-5.
26. Fairbanks CA, Stone LS, Kitto KF, et al. α 2c-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther 2002;300:282-90.
27. Stone LS, Kitto KF, Eisenach JC, Fairbanks CA, Wilcox GL. ST91 (2-[2, 6-diethylphenylamino]-2-imidazoline hydrochloride)-mediated spinal antinociception and synergy with opioids persists in the absence of functional α -2A- or α -2C-adrenergic receptors. J Pharmacol Exp Ther 2007;323:899-906.
28. Fairbanks CA, Kitto KF, Nguyen HO, Stone LS, Wilcox GL. Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord. Anesthesiology 2009;110:638-47.
29. Simonnet G. Preemptive antihyperalgesia to improve preemptive analgesia. Anesthesiology 2008;108:352-4.
30. Wilder-Smith OHG, Arendt-Nielsen L. Postoperative hyperalgesia. Anesthesiology 2006;104:601-7.
31. Compton P. The OIH paradox: Can opioids make pain worse. Available at: (accessed August 20 2008).
32. Chen L, Malarick C, Seefeld L, et al. Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 2009;143:65-70.